Showing all posts written by Sabrina Wang

Sabrina Wang
Sabrina Wang
Sabrina Wang is an associate in our Orange County office.

Ms. Wang received her Bachelor's Degree in Bioengineering in 2007 from National University of Singapore. After graduation, she worked as an engineer developing orthopedic devices in Utah and Singapore.

In 2015, Ms. Wang graduated from the University of Virginia School of Law. While attending law school, Ms. Wang served on the Article Review Board of Virginia Journal of Law & Technology in her second year.

Ms. Wang was a summer associate at the firm in 2014 and joined the firm as an associate in 2015.
Click here to read full bio

Smith & Nephew, Arthrex Settled Suture Anchor Patent Dispute Before Trial

On February 14, 2017, U.S. District Judge Michael Mosman of the United States District Court, District of Oregon granted a Joint Stipulated Motion for Dismissal with Prejudice submitted by Plaintiffs Smith & Nephew, Inc. and John

Symfony Lens

First Extended-Range Intraocular Lens Receives FDA Approval

The U.S. Food and Drug Administration (FDA) has approved Abbott’s Tecnis Symfony Intraocular Lenses (IOL) for treating cataracts.  According to Abbott, the Tecnis Symfony lenses are currently the only lenses in the United

First U.S. Implant of St. Jude’s First-to-Market “CRT-D”

St. Jude Medical, Inc. recently announced the U.S. launch and the first U.S. implant of its Quadra Assure MP cardiac resynchronization therapy defibrillator (CRT-D).  The Quadra Assura MP features St. Jude Medical’s

Roche Adds FDA-Approved HIV-1 Assay To Its Cobas® 6800/8000 Systems

Roche Adds FDA-Approved HIV-1 Assay To Its Cobas® 6800/8000 Systems

Swiss biotech company Roche announced on December 21, 2015 that the FDA has approved the Cobas® 6800 and 8800 Systems from its Pleasanton, California-based Roche Molecular Diagnostics (RMD) for the Cobas® HIV-1 viral load

St. Jude Medical Completes Acquisition of Thoratec

St. Jude Medical, Inc. recently announced that it has completed its acquisition of Thoratec Corporation. In July 2015, St. Jude Medical announced its offer to buy Thoratec shares at $63.50 per share. The transaction is valued at about $3.3